{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T01:07:04Z","timestamp":1768612024143,"version":"3.49.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,9,26]]},"DOI":"10.7759\/cureus.18289","type":"journal-article","created":{"date-parts":[[2021,9,26]],"date-time":"2021-09-26T07:24:06Z","timestamp":1632641046000},"source":"Crossref","is-referenced-by-count":2,"title":["Prevalence of Thyroid Dysfunction in Patients With Hepatitis C"],"prefix":"10.7759","author":[{"given":"Kefayatullah","family":"Nazary","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sana","family":"Anwar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ankita Y","family":"Choudhary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepa","family":"Malla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farukhzad","family":"Hafizyar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdul Subhan","family":"Talpur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faryal","family":"Fatima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marjan","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v7.i10.1377","article-title":"Hepatitis C virus: virology, diagnosis and treatment","volume":"7","author":"Li HC","year":"2015","unstructured":"Li HC, Lo SY. Hepatitis C virus: virology, diagnosis and treatment. World J Hepatol. 2015, 7:1377-89. 10.4254\/wjh.v7.i10.1377","journal-title":"World J Hepatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/s0168-8278(99)80369-9","article-title":"Natural history of hepatitis C","volume":"31","author":"Alberti A","year":"1999","unstructured":"Alberti A, Chemello L, Benvegn\u00f9 L. Natural history of hepatitis C. J Hepatol. 1999, 31:17-24. 10.1016\/s0168-8278(99)80369-9","journal-title":"J Hepatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2002.36227","article-title":"Course and outcome of hepatitis C","volume":"36","author":"Hoofnagle JH","year":"2002","unstructured":"Hoofnagle JH. Course and outcome of hepatitis C. Hepatology. 2002, 36:S21-9. 10.1053\/jhep.2002.36227","journal-title":"Hepatology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.3.47","article-title":"The natural history of hepatitis C virus (HCV) infection","volume":"3","author":"Chen SL","year":"2006","unstructured":"Chen SL, Morgan TR. The natural history of hepatitis C virus (HCV) infection. Int J Med Sci. 2006, 3:47-52. 10.7150\/ijms.3.47","journal-title":"Int J Med Sci"},{"key":"ref5","article-title":"Autoimmune diseases co-existing with hepatitis C virus infection","volume":"9","author":"Jadali Z","year":"2010","unstructured":"Jadali Z, Alavian SM. Autoimmune diseases co-existing with hepatitis C virus infection. Iran J Allergy Asthma Immunol. 2010, 9:191-206.","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2004.01.023","article-title":"Thyroid disorders in chronic hepatitis C","volume":"117","author":"Antonelli A","year":"2004","unstructured":"Antonelli A, Ferri C, Pampana A, et al.. Thyroid disorders in chronic hepatitis C. Am J Med. 2004, 117:10-3. 10.1016\/j.amjmed.2004.01.023","journal-title":"Am J Med"},{"key":"ref7","article-title":"Prevalence of hepatitis B and C viral infections in Pakistan: findings of a national survey appealing for effective prevention and control measures","volume":"16 Suppl","author":"Qureshi H","year":"2010","unstructured":"Qureshi H, Bile KM, Jooma R, Alam SE, Afridi HU. Prevalence of hepatitis B and C viral infections in Pakistan: findings of a national survey appealing for effective prevention and control measures. East Mediterr Health J. 2010, 16 Suppl:S15-23.","journal-title":"East Mediterr Health J"},{"key":"ref8","article-title":"Prevalence of HCV antibodies in autoimmune thyroid disease","volume":"10","author":"Testa A","year":"2006","unstructured":"Testa A, Castaldi P, Fant V, et al.. Prevalence of HCV antibodies in autoimmune thyroid disease. Eur Rev Med Pharmacol Sci. 2006, 10:183-6.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1006\/jaut.1999.0360","article-title":"Latent autoimmune thyroiditis in untreated patients with HCV chronic hepatitis: a case-control study","volume":"14","author":"Ganne-Carrie N","year":"2000","unstructured":"Ganne-Carrie N, Medini A, Coderc E, et al.. Latent autoimmune thyroiditis in untreated patients with HCV chronic hepatitis: a case-control study. J Autoimmun. 2000, 14:189-93. 10.1006\/jaut.1999.0360","journal-title":"J Autoimmun"},{"key":"ref10","doi-asserted-by":"crossref","DOI":"10.1002\/hep.1840180205","article-title":"High prevalence of thyroid autoantibodies in a prospective series of patients with chronic hepatitis C before interferon therapy","volume":"18","author":"Tran A","year":"1993","unstructured":"Tran A, Quaranta JF, Benzaken S, et al.. High prevalence of thyroid autoantibodies in a prospective series of patients with chronic hepatitis C before interferon therapy. Hepatology. 1993, 18:253-7.","journal-title":"Hepatology"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1420431","article-title":"Virologic factors related to interferon-alpha-induced thyroid dysfunction in patients with chronic hepatitis C","volume":"142","author":"Hsieh MC","year":"2000","unstructured":"Hsieh MC, Yu ML, Chuang WL, et al.. Virologic factors related to interferon-alpha-induced thyroid dysfunction in patients with chronic hepatitis C. Eur J Endocrinol. 2000, 142:431-7. 10.1530\/eje.0.1420431","journal-title":"Eur J Endocrinol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/s0168-8278(05)80022-4","article-title":"High prevalence of antibodies to hepatitis C virus (HCV) in patients with anti-thyroid autoantibodies","volume":"18","author":"Quaranta JF","year":"1993","unstructured":"Quaranta JF, Tran A, R\u00e9gnier D, et al.. High prevalence of antibodies to hepatitis C virus (HCV) in patients with anti-thyroid autoantibodies. J Hepatol. 1993, 18:136-8. 10.1016\/s0168-8278(05)80022-4","journal-title":"J Hepatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2005.00699.x","article-title":"Is hepatitis C virus a risk factor for thyroid autoimmunity?","volume":"13","author":"Floreani A","year":"2006","unstructured":"Floreani A, Betterle C, Carderi I, et al.. Is hepatitis C virus a risk factor for thyroid autoimmunity?. J Viral Hepat. 2006, 13:272-7. 10.1111\/j.1365-2893.2005.00699.x","journal-title":"J Viral Hepat"},{"key":"ref14","article-title":"Interferon-alpha induced and ribavirin induced thyroid dysfunction in patients with chronic hepatitis C","volume":"10","author":"Nadeem A","year":"2010","unstructured":"Nadeem A, Hussain MM, Aslam M, Hussain T. Interferon-alpha induced and ribavirin induced thyroid dysfunction in patients with chronic hepatitis C. Hepat Mon. 2010, 10:132-40.","journal-title":"Hepat Mon"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9343(96)00259-8","article-title":"Multiple changes in thyroid function in patients with chronic active HCV hepatitis treated with recombinant interferon-alpha","volume":"101","author":"Roti E","year":"1996","unstructured":"Roti E, Minelli R, Giuberti T, et al.. Multiple changes in thyroid function in patients with chronic active HCV hepatitis treated with recombinant interferon-alpha. Am J Med. 1996, 101:482-7. 10.1016\/s0002-9343(96)00259-8","journal-title":"Am J Med"},{"key":"ref16","article-title":"Thyroid gland dysfunctions during antiviral therapy of chronic hepatitis C","volume":"7","author":"Kryczka W","year":"2001","unstructured":"Kryczka W, Brojer E, Kowalska A, Zarebska-Michaluk D. Thyroid gland dysfunctions during antiviral therapy of chronic hepatitis C. Med Sci Monit. 2001, 7:221-5.","journal-title":"Med Sci Monit"},{"key":"ref17","article-title":"Patients with chronic hepatitis type C and interferon-alpha-induced hyperthyroidism in two-years clinical follow-up","volume":"34","author":"Czarnywojtek A","year":"2013","unstructured":"Czarnywojtek A, Zgorzalewicz-Stachowiak M, Wasko R, et al.. Patients with chronic hepatitis type C and interferon-alpha-induced hyperthyroidism in two-years clinical follow-up. Neuro Endocrinol Lett. 2013, 34:154-61.","journal-title":"Neuro Endocrinol Lett"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/70689-prevalence-of-thyroid-dysfunction-in-patients-with-hepatitis-c","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:34:39Z","timestamp":1707507279000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/70689-prevalence-of-thyroid-dysfunction-in-patients-with-hepatitis-c"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,26]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.18289","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9,26]]}}}